Search by Name_2.xlsm |
---|
|
---|
| A | B | C | D | E | F | G | H | I | J | K | L | M |
---|
1 | | | | | | | | | | | | | |
---|
2 | | CRITERIA | | | | | DATA BASE | | |
---|
3 | | Customer Name | Product Name Abbreviation | | | EXCLUSIVES CUSTOMERS | EXCLUSIVES MONTH | Customer Name | Month | Product Name | Units | | |
---|
4 | | ABA | sinva | | | ABA | jan. 2023 | ABA | feb. 2023 | ESPIRONOLACTONA 100 MG - 60 COMP. | 1 | | |
---|
5 | | | | | | CNY | feb. 2023 | ABA | jan. 2023 | SINVASTATINA 20 MG - 60 COMP. | 80 | 161 | |
---|
6 | | | rosuva + ezet | | | DIL | | ABA | jan. 2023 | SINVASTATINA 20 MG - 60 COMP. | 81 | 161 | |
---|
7 | | | | | | | | ABA | feb. 2023 | AMLODIPINA 10 mg - 60 Com | 20 | | |
---|
8 | | | | | | | | ABA | jan. 2023 | PRAVASTATINA 20 MG - 60 COMP. | 2 | | |
---|
9 | | | | | | | | ABA | feb. 2023 | NIFEDIPINA 20 MG - 60 COMP. | 5 | | |
---|
10 | | Month | | | Month | | | ABA | feb. 2023 | SINVASTATINA 40 MG - 60 COMP. | 2 | | |
---|
11 | | jan. 2023 | | | feb. 2023 | | | ABA | feb. 2023 | ROSUVASTATINA + EZETIMIBA 20 + 10 mg 60 | 4 | | |
---|
12 | | | | | | | | ABA | jan. 2023 | SERTRALINA 50 MG - 60 COMP. | 24 | | |
---|
13 | | RESULTS OF CRITERIA TABLE ABOVE | | | RESULTS OF CRITERIA TABLE ABOVE | | | ABA | jan. 2023 | SERTRALINA 100 MG - 60 COMP. | 20 | | |
---|
14 | | Product Name | Sum Units | | Product Name | Sum Units | | ABA | feb. 2023 | ROSUVASTATINA + EZETIMIBA 20 + 10 mg 60 | 16 | | |
---|
15 | | SINVASTATINA 20 MG - 60 COMP. | 161 | | ESPIRONOLACTONA 100 MG - 60 COMP. | | | CNY | feb. 2023 | RAMIPRIL 2,5 MG - 56 CAPS. | 2 | | |
---|
16 | | | | | SINVASTATINA 20 MG - 60 COMP. | 161 | | CNY | feb. 2023 | RAMIPRIL 5 MG - 56 CAPS. | 6 | | |
---|
17 | | | | | AMLODIPINA 10 mg - 60 Com | | | CNY | feb. 2023 | RAMIPRIL 10 MG - 56 CAPS. | 6 | | |
---|
18 | | | | | PRAVASTATINA 20 MG - 60 COMP. | | | CNY | feb. 2023 | RAMIPRIL + HCTZ 5 MG/25 MG - 56 COMP. | 1 | | |
---|
19 | | | | | NIFEDIPINA 20 MG - 60 COMP. | | | CNY | feb. 2023 | OLANZAPINA 2,5X28 MG | 4 | | |
---|
20 | | | | | SINVASTATINA 40 MG - 60 COMP. | | | CNY | jan. 2023 | PANTOPRAZOL 20 MG - 56 COMP.GASTRO-RESIST. | 2 | | |
---|
21 | | | | | ROSUVASTATINA + EZETIMIBA 20 + 10 mg 60 | | | CNY | feb. 2023 | AMLOD+OLME+HCTZ 5 MG +20 MG +12,5 MG 56 | 69 | | |
---|
22 | | | | | SERTRALINA 50 MG - 60 COMP. | | | CNY | jan. 2023 | MONTELUCASTE 10MG 28COMP | 2 | | |
---|
23 | | | | | SERTRALINA 100 MG - 60 COMP. | | | CNY | feb. 2023 | AMLOD+OLME+HCTZ 5 MG +20 MG +12,5 MG 56 | 1 | | |
---|
24 | | | | | RAMIPRIL 2,5 MG - 56 CAPS. | | | CNY | feb. 2023 | PANTOPRAZOL 40 MG - 56 COMP.GASTRO-RESIST | 2 | | |
---|
25 | | | | | RAMIPRIL 5 MG - 56 CAPS. | | | CNY | jan. 2023 | EBASTINA 10MG-20 COMP | 6 | | |
---|
26 | | | | | RAMIPRIL 10 MG - 56 CAPS. | | | DIL | feb. 2023 | QUETIAPINA 25MG 20 COMP | 12 | | |
---|
27 | | | | | RAMIPRIL + HCTZ 5 MG/25 MG - 56 COMP. | | | DIL | feb. 2023 | MONTELUCASTE 10MG 28COMP | 2 | | |
---|
28 | | | | | OLANZAPINA 2,5X28 MG | | | DIL | feb. 2023 | ESPIRONOLACTONA 25 MG - 60 COMP. | 20 | | |
---|
29 | | | | | PANTOPRAZOL 20 MG - 56 COMP.GASTRO-RESIST. | | | DIL | feb. 2023 | METFORMINA + VILDAGLIPTINA 1000 + 50 mg 60 | 4 | | |
---|
30 | | | | | AMLOD+OLME+HCTZ 5 MG +20 MG +12,5 MG 56 | | | DIL | jan. 2023 | CLOPIDOGREL GENERICOS 75MG 28C | 50 | | |
---|
31 | | | | | MONTELUCASTE 10MG 28COMP | | | DIL | feb. 2023 | IRBESARTAN+HCTZ 150 12,5 28MG | 4 | | |
---|
32 | | | | | PANTOPRAZOL 40 MG - 56 COMP.GASTRO-RESIST | | | DIL | jan. 2023 | IRBESARTAN+HCTZ 300 12,5 28MG | 2 | | |
---|
33 | | | | | EBASTINA 10MG-20 COMP | | | DIL | feb. 2023 | METFORMINA + VILDAGLIPTINA 1000 + 50 mg 60 | 3 | | |
---|
34 | | | | | QUETIAPINA 25MG 20 COMP | | | | | | | | |
---|
35 | | | | | ESPIRONOLACTONA 25 MG - 60 COMP. | | | | | | | | |
---|
36 | | | | | METFORMINA + VILDAGLIPTINA 1000 + 50 mg 60 | | | | | | | | |
---|
37 | | | | | CLOPIDOGREL GENERICOS 75MG 28C | | | | | | | | |
---|
38 | | | | | IRBESARTAN+HCTZ 150 12,5 28MG | | | | | | | | |
---|
39 | | | | | IRBESARTAN+HCTZ 300 12,5 28MG | | | | | | | | |
---|
40 | | | | | | | | | | | | | |
---|
41 | | | | | | | | | | | | | |
---|
|
---|